17May/13

SIMPONI (GOLIMUMAB) Receives FDA Approval For Ulcerative Colitis – PipelineReview.com (press release)


6abc.com

SIMPONI (GOLIMUMAB) Receives FDA Approval For Ulcerative Colitis
PipelineReview.com (press release)
HORSHAM, PA, USA I May 15, 2013 I Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI® (golimumab) for the treatment of moderately to severely active ulcerative colitis (UC) in adult patients
FDA: Arthritis drug OKed to treat bowel diseaseThe Star-Ledger – NJ.com

all 21 news articles »